BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38591191)

  • 21. Expression of CHPF modulates cell proliferation and invasion in lung cancer.
    Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J
    Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization.
    Kitagawa H; Izumikawa T; Uyama T; Sugahara K
    J Biol Chem; 2003 Jun; 278(26):23666-71. PubMed ID: 12716890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment.
    Liao WC; Yen HR; Chen CH; Chu YH; Song YC; Tseng TJ; Liu CH
    Am J Cancer Res; 2021; 11(3):812-826. PubMed ID: 33791155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinol inhibits growth of malignant melanoma cells via regulating miR-1207-5p/CHPF pathway.
    Wang Y; Zhang D
    Arch Dermatol Res; 2020 Jul; 312(5):373-383. PubMed ID: 31828417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer.
    Wu ZY; He YQ; Wang TM; Yang DW; Li DH; Deng CM; Cao LJ; Zhang JB; Xue WQ; Jia WH
    Front Cell Dev Biol; 2021; 9():763875. PubMed ID: 34966741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.
    Izumikawa T; Uyama T; Okuura Y; Sugahara K; Kitagawa H
    Biochem J; 2007 May; 403(3):545-52. PubMed ID: 17253960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer.
    Hou XM; Baloch Z; Zheng ZH; Zhang WH; Feng Y; Li DD; Wu XA; Yang SH
    Cancer Manag Res; 2019; 11():3275-3283. PubMed ID: 31118773
    [No Abstract]   [Full Text] [Related]  

  • 28. RNF180 Inhibits Proliferation and Promotes Apoptosis of Colorectal Cancer Through Ubiquitination of WISP1.
    Wei F; Ba S; Jin M; Ci R; Wang X; E F; Long Z
    Front Cell Dev Biol; 2020; 8():623455. PubMed ID: 33553163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

  • 31. Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer.
    Liu L; Chen Y; Lin X; Wu M; Li J; Xie Q; Sferra TJ; Han Y; Liu H; Cao L; Yao M; Peng J; Shen A
    Cancer Cell Int; 2021 Oct; 21(1):547. PubMed ID: 34663329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
    Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
    Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles derived from hypoxic HTR-8/SVneo trophoblast inhibit endothelial cell functions through the miR-150-3p /CHPF pathway.
    Sha M; Zhang S; Beejadhursing R; Sun Y; Qin Y; Chen S; Li W
    Placenta; 2023 Jul; 138():21-32. PubMed ID: 37156185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topoisomerase IIβ binding protein 1 serves as a novel prognostic biomarker for stage II-III colorectal cancer patients.
    Wang Y; Yan X; Qu X; Mao J; Wang J; Yang M; Tao M
    Pathol Res Pract; 2023 Jan; 241():154287. PubMed ID: 36586311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
    Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
    Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
    Mao D; Zhang X; Wang Z; Xu G; Zhang Y
    Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AHR Regulates NK Cell Migration
    Shin JH; Moreno-Nieves UY; Zhang LH; Chen C; Dixon AL; Linde MH; Mace EM; Sunwoo JB
    Front Immunol; 2021; 12():624284. PubMed ID: 33717133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans.
    Laabs TL; Wang H; Katagiri Y; McCann T; Fawcett JW; Geller HM
    J Neurosci; 2007 Dec; 27(52):14494-501. PubMed ID: 18160657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.
    Bian Z; Zhou M; Cui K; Yang F; Cao Y; Sun S; Liu B; Gong L; Li J; Wang X; Li C; Yao S; Yin Y; Huang S; Fei B; Huang Z
    J Exp Clin Cancer Res; 2021 Nov; 40(1):360. PubMed ID: 34782005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.